title: Advances in understanding the pulmonary infiltration in acute promyelocytic leukaemia.
abstract: In acute promyelocytic leukaemia (APL), differentiation therapy can be complicated by the development of a differentiation syndrome (DS). Pulmonary infiltration of differentiating leukaemic cells is a key event in the development of DS. Several mediators have been identified that may promote migration and extravasation of differentiating APL cells from the bloodstream into the tissue. Adhesion of APL cells to each other and to the endothelium is induced by upregulation of the expression of adhesion molecules and constitutively active β2-integrins during differentiation therapy. The expression of chemokines and their receptors is significantly upregulated as well. Pulmonary chemokine production can trigger transendothelial migration of differentiating APL cells from the bloodstream into the underlying tissue (initiation phase of DS). Massive production of chemokines by infiltrated APL cells can further enhance transendothelial migration of differentiating APL cells, causing an uncontrollable hyperinflammatory reaction in the lung (aggravation phase), which is not efficiently switched-off by corticosteroids.
authors.affiliation: Radboud University Nijmegen Medical Centre, The Netherlands.
authors.forename: Maaike
authors.initials: M
authors.lastname: Luesink
authors.forename: Joop H
authors.initials: JH
authors.lastname: Jansen
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects; D002448:Cell Adhesion / Q000502:physiology; D002454:Cell Differentiation / Q000187:drug effects; D018925:Chemokines / Q000502:physiology; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000473:pathology*; D017254:Leukemic Infiltration / Q000473:pathology*; D008168:Lung / Q000473:pathology*; D008954:Models, Biological; D013577:Syndrome
chemical_list: D000970:Antineoplastic Agents; D018925:Chemokines